Genetic Signatures’ CEO & CSO presenting at Gene Target Solutions Symposium, Sydney Australia.

Molecular diagnostics (MDx) company Genetic Signatures’ CEO Dr John Melki and CSO Dr Doug Miller will present at the inaugural Gene Target Solutions Symposium: qPCR, Past Present and Future on the 13-14^th March 2017 in Sydney, Australia.

CEO Dr Melki’s presentation is entitled “History of 3base™ technology and its application in molecular diagnostics.” The presentation will highlight the background of Genetic Signatures novel technology and its utilisation in the field of Molecular Diagnostics.

The second presentation by CSO Dr Miller is entitled, “Application of 3base™ technology to the detection of diverse families of both DNA and RNA viruses.” Dr Miller will discuss the molecular applications of Genetic Signatures 3base™ technology for species identification of infectious pathogens.

Meet Genetic Signatures CEO and CSO at qPCR Symposium Australia for more information.

Click here to visit the qPCR Symposium Australia website 

About Gene Target Solutions Symposium: qPCR Symposium Australia is a conference featuring renowned International and Australian speakers. This inaugural symposium hosted by Australian owned company Gene Target Solutions, is the first and only Australian event purely dedicated to qPCR.